Ali A. Rizvi

TitleCLINICAL PROFESSOR-USC
InstitutionUniversity of South Carolina School of Medicine
DepartmentMDC INTERNAL MEDICINE
Address5 MEDICAL PARK
Columbia, South Carolina 29203
Phone(803)545-5342
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Giglio RV, Pantea Stoian A, Al-Rasadi K, Banach M, Patti AM, Ciaccio M, Rizvi AA, Rizzo M. Novel Therapeutical Approaches to Managing Atherosclerotic Risk. Int J Mol Sci. 2021 Apr 28; 22(9). PMID: 33924893.
      Citations:    
    2. Giglio RV, Stoian AP, Patti AM, Rizvi AA, Sukhorukov V, Ciaccio M, Orekhov A, Rizzo M. Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome. Curr Pharm Des. 2021 Apr 12. PMID: 33845722.
      Citations:    
    3. Nikolic D, Giglio RV, Rizvi AA, Patti AM, Montalto G, Maranta F, Cianflone D, Stoian AP, Rizzo M. Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect. Diabetes Ther. 2021 Jan; 12(1):261-274. PMID: 33210276.
      Citations:    
    4. Giglio RV, Carruba G, Cicero AFG, Banach M, Patti AM, Nikolic D, Cocciadiferro L, Zarcone M, Montalto G, Stoian AP, Banerjee Y, Rizvi AA, Toth PP, Rizzo M. Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study. Metabolites. 2020 Oct 26; 10(11). PMID: 33114614.
      Citations:    
    5. Patti AM, Carruba G, Cicero AFG, Banach M, Nikolic D, Giglio RV, Terranova A, Soresi M, Giannitrapani L, Montalto G, Stoian AP, Banerjee Y, Rizvi AA, Toth PP, Rizzo M. Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study. Metabolites. 2020 Oct 02; 10(10). PMID: 33023123.
      Citations:    
    6. Giglio RV, Nikolic D, Volti GL, Stoian AP, Banerjee Y, Magan-Fernandez A, Castellino G, Patti AM, Chianetta R, Castracani CC, Montalto G, Rizvi AA, Sesti G, Rizzo M. Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect. Metabolites. 2020 Sep 30; 10(10). PMID: 33008044.
      Citations:    
    7. Sachinidis A, Nikolic D, Stoian AP, Papanas N, Tarar O, Rizvi AA, Rizzo M. Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors. Metabolism. 2020 10; 111:154343. PMID: 32810485.
      Citations:    
    8. Stoian AP, Papanas N, Prazny M, Rizvi AA, Rizzo M. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. J Cardiovasc Pharmacol Ther. 2020 11; 25(6):494-496. PMID: 32618198.
      Citations:    
    9. Stoian AP, Sachinidis A, Stoica RA, Nikolic D, Patti AM, Rizvi AA. The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes. Metabolism. 2020 08; 109:154295. PMID: 32553739.
      Citations:    
    10. Stoian AP, Banerjee Y, Rizvi AA, Rizzo M. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. Metab Syndr Relat Disord. 2020 05; 18(4):173-175. PMID: 32271125.
      Citations:    
    11. Patti AM, Rizvi AA, Giglio RV, Stoian AP, Ligi D, Mannello F. Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes. J Clin Med. 2020 Mar 26; 9(4). PMID: 32225082.
      Citations:    
    12. Cianflone D, Rizvi AA, Rizzo M. Microvascular and macrovascular effects of liraglutide. Int J Cardiol. 2019 07 01; 286:17-18. PMID: 30878237.
      Citations:    
    13. Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M. Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study. Diabetes Res Clin Pract. 2019 Mar; 149:163-169. PMID: 30759365.
      Citations:    
    14. Patti AM, Giglio RV, Papanas N, Rizzo M, Rizvi AA. Future perspectives of the pharmacological management of diabetic dyslipidemia. Expert Rev Clin Pharmacol. 2019 Feb; 12(2):129-143. PMID: 30644763.
      Citations:    
    15. Mahboob R, Rizvi AA. VISUAL VIGNETTE. Endocr Pract. 2018 Dec; 24(12):1110. PMID: 30106631.
      Citations:    
    16. Rizzo M, Nikolic D, Patti AM, Mannina C, Montalto G, McAdams BS, Rizvi AA, Cosentino F. GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms. Biochim Biophys Acta Mol Basis Dis. 2018 09; 1864(9 Pt B):2814-2821. PMID: 29778663.
      Citations:    
    17. Rizvi AA. Thyroid Dysfunction in Torsades de Pointes. JAMA Intern Med. 2017 11 01; 177(11):1693. PMID: 29114788.
      Citations:    
    18. Rizvi AA. ADDRESSING HYPERTENSION IN THE PATIENT WITH TYPE 2 DIABETES MELLITUS: PATHOGENESIS, GOALS, AND THERAPEUTIC APPROACH. Eur Med J Diabetes. 2017 Oct; 5(1):84-92. PMID: 29129996.
      Citations:    
    19. Rizzo M, Rizvi AA, Sesti G. Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes. Diabetes Obes Metab. 2017 05; 19(5):613-614. PMID: 28098425.
      Citations:    
    20. Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G, Li Volti G, Caprio M, Montalto G, Provenzano V, Genovese S, Ceriello A. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study. Cardiovasc Diabetol. 2016 Dec 03; 15(1):162. PMID: 27912784.
      Citations:    
    21. Rizvi AA. TREATMENT OF TYPE 2 DIABETES WITH BIPHASIC INSULIN ANALOGUES. Eur Med J Diabetes. 2016; 4(1):74-83. PMID: 27918600.
      Citations:    
    22. Rizvi AA. The evolving role of bariatric surgery in patients with type 1 diabetes and obesity. Integr Obes Diabetes. 2016; 2(2):195-199. PMID: 27398228.
      Citations:    
    23. McAdams BH, Rizvi AA. An Overview of Insulin Pumps and Glucose Sensors for the Generalist. J Clin Med. 2016 Jan 04; 5(1). PMID: 26742082.
      Citations:    
    24. Nikolic D, Al-Rasadi K, Al Busaidi N, Al-Waili K, Banerjee Y, Al-Hashmi K, Montalto G, Rizvi AA, Rizzo M, Al-Dughaishi T. Incretins, Pregnancy, and Gestational Diabetes. Curr Pharm Biotechnol. 2016; 17(7):597-602. PMID: 26813306.
      Citations:    
    25. Rizvi AA, Brennan JR. Giant Intracranial Aneurysm Masquerading in the Sella. Am J Med Sci. 2016 Jan; 351(1):119. PMID: 26802768.
      Citations:    
    26. Hoppmann RA, Rao VV, Bell F, Poston MB, Howe DB, Riffle S, Harris S, Riley R, McMahon C, Wilson LB, Blanck E, Richeson NA, Thomas LK, Hartman C, Neuffer FH, Keisler BD, Sims KM, Garber MD, Shuler CO, Blaivas M, Chillag SA, Wagner M, Barron K, Davis D, Wells JR, Kenney DJ, Hall JW, Bornemann PH, Schrift D, Hunt PS, Owens WB, Smith RS, Jackson AG, Hagon K, Wilson SP, Fowler SD, Catroppo JF, Rizvi AA, Powell CK, Cook T, Brown E, Navarro FA, Thornhill J, Burgis J, Jennings WR, McCallum JB, Nottingham JM, Kreiner J, Haddad R, Augustine JR, Pedigo NW, Catalana PV. The evolution of an integrated ultrasound curriculum (iUSC) for medical students: 9-year experience. Crit Ultrasound J. 2015 Dec; 7(1):18. PMID: 26589313.
      Citations:    
    27. Rizvi AA, Patti AM, Giglio RV, Nikolic D, Amato A, Al-Busaidi N, Al-Rasadi K, Soresi M, Banach M, Montalto G, Rizzo M. Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study. Expert Opin Biol Ther. 2015; 15(10):1391-7. PMID: 26195184.
      Citations:    
    28. Machado MC, Bruce-Mensah A, Whitmire M, Rizvi AA. Hypercalcemia Associated with Calcium Supplement Use: Prevalence and Characteristics in Hospitalized Patients. J Clin Med. 2015 Mar 09; 4(3):414-24. PMID: 26239247.
      Citations:    
    29. Rizzo M, Al-Busaidi N, Rizvi AA. Dapagliflozin therapy in type-2 diabetes: current knowledge and future perspectives. Expert Opin Pharmacother. 2015 Feb; 16(3):281-4. PMID: 25516459.
      Citations:    
    30. Rizzo M, Abate N, Chandalia M, Rizvi AA, Giglio RV, Nikolic D, Marino Gammazza A, Barbagallo I, Isenovic ER, Banach M, Montalto G, Li Volti G. Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study. J Clin Endocrinol Metab. 2015 Feb; 100(2):603-6. PMID: 25393640.
      Citations:    
    31. Tripathi A, Liese AD, Winniford MD, Jerrell JM, Albrecht H, Rizvi AA, Zhang J, Duffus WA. Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults. Clin Cardiol. 2014 Sep; 37(9):517-22. PMID: 25223811.
      Citations:    
    32. Rizzo M, Chandalia M, Patti AM, Di Bartolo V, Rizvi AA, Montalto G, Abate N. Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. Cardiovasc Diabetol. 2014 Feb 22; 13:49. PMID: 24559258.
      Citations:    
    33. Williams E, Chillag S, Rizvi A. Thyroid bruit and the underlying 'inferno'. Am J Med. 2014 Jun; 127(6):489-90. PMID: 24447837.
      Citations:    
    34. Huggins EA, Chillag SA, Rizvi AA, Moran RR, Durkin MW. Diabetic ketoalkalosis in children and adults. South Med J. 2014 Jan; 107(1):6-10. PMID: 24389778.
      Citations:    
    35. Rizvi AA, Cuadra S, Nikolic D, Giglio RV, Montalto G, Rizzo M. Gestational diabetes and the metabolic syndrome: can obesity and small, dense low density lipoproteins be key mediators of this association? Curr Pharm Biotechnol. 2014; 15(1):38-46. PMID: 24720595.
      Citations:    
    36. Rizzo M, Nikolic D, Banach M, Patti AM, Montalto G, Rizvi AA. Incretin-based therapies, glucometabolic health and endovascular inflammation. Curr Pharm Des. 2014; 20(31):4953-60. PMID: 24320037.
      Citations:    
    37. Rizzo M, Obradovic M, Labudovic-Borovic M, Nikolic D, Montalto G, Rizvi AA, Mikhailidis DP, Isenovic ER. Uric acid metabolism in pre-hypertension and the metabolic syndrome. Curr Vasc Pharmacol. 2014; 12(4):572-85. PMID: 23627979.
      Citations:    
    38. Rizvi AA, Nikolic D, Sallam HS, Montalto G, Rizzo M, Abate N. Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. Metab Syndr Relat Disord. 2014 Feb; 12(1):1-10. PMID: 24206170.
      Citations:    
    39. Machado MC, Rizvi AA. The "calcium supplement syndrome": modern-day reemergence of a bygone disorder. J S C Med Assoc. 2013 Sep; 109(3):88-91. PMID: 24261156.
      Citations:    
    40. Tripathi A, Jerrell JM, Liese AD, Zhang J, Rizvi AA, Albrecht H, Duffus WA. Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011. Metab Syndr Relat Disord. 2013 Dec; 11(6):417-26. PMID: 23909647.
      Citations:    
    41. Rizzo M, Avogaro A, Montalto G, Rizvi AA. Non-glycemic effects of pioglitazone and incretin-based therapies. Expert Opin Ther Targets. 2013 Jul; 17(7):739-42. PMID: 23691979.
      Citations:    
    42. Rizzo M, Barylski M, Rizvi AA, Montalto G, Mikhailidis DP, Banach M. Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia? Curr Pharm Des. 2013; 19(21):3858-68. PMID: 23286436.
      Citations:    
    43. Rizzo M, Rizvi AA, Sudar E, Soskic S, Obradovic M, Montalto G, Boutjdir M, Mikhailidis DP, Isenovic ER. A review of the cardiovascular and anti-atherogenic effects of ghrelin. Curr Pharm Des. 2013; 19(27):4953-63. PMID: 23278489.
      Citations:    
    44. Aziz SA, Singer MC, Terris DJ, Rizvi AA. Visual vignette. Endocr Pract. 2012 Nov-Dec; 18(6):1039. PMID: 22784852.
      Citations:    
    45. Tripathi A, Rizvi AA, Knight LM, Jerrell JM. Prevalence and impact of initial misclassification of pediatric type 1 diabetes mellitus. South Med J. 2012 Oct; 105(10):513-7. PMID: 23038480.
      Citations:    
    46. Rizvi AA, Montalto G, Patti AM, Rizzo M. Oxidative stress and small, dense low-density lipoproteins: current and future perspectives. Expert Rev Endocrinol Metab. 2012 Jul; 7(4):415-417. PMID: 30754159.
      Citations:    
    47. Aamir S, Rizvi AA. Visual vignette. Suppurative thyroiditis due to Nocardia asteroides. Endocr Pract. 2012 May-Jun; 18(3):426. PMID: 22592052.
      Citations:    
    48. Rizzo M, Montalto G, Rizvi AA, Christ ER. The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly. Angiology. 2012 Oct; 63(7):492-4. PMID: 22371625.
      Citations:    
    49. Shlapack MA, Rizvi AA, Lopez FA. Normocalcemic primary hyperparathyroidism-characteristics and clinical significance of an emerging entity. Am J Med Sci. 2012 Feb; 343(2):163-166. PMID: 22173046.
      Citations:    
    50. Jerrell JM, Tripathi A, Rizvi AA, McIntyre RS. The risk of developing type 2 diabetes mellitus associated with psychotropic drug use in children and adolescents: a retrospective cohort analysis. Prim Care Companion CNS Disord. 2012; 14(1). PMID: 22690363.
      Citations:    
    51. Tonda C, Rizvi AA. Headache, pituitary lesion and panhypopituitarism in a pregnant woman: tumor, apoplexy or hypophysitis? Am J Med Sci. 2011 Sep; 342(3):247-9. PMID: 21681070.
      Citations:    
    52. Patel R, Rizvi AA. Vitamin D deficiency in patients with congestive heart failure: mechanisms, manifestations, and management. South Med J. 2011 May; 104(5):325-30. PMID: 21606710.
      Citations:    
    53. Rizvi AA. Hypertension, obesity, and inflammation: the complex designs of a deadly trio. Metab Syndr Relat Disord. 2010 Aug; 8(4):287-94. PMID: 20367224.
      Citations:    
    54. Rizvi AA, Chillag SA, Chillag KJ. Perioperative management of diabetes and hyperglycemia in patients undergoing orthopaedic surgery. J Am Acad Orthop Surg. 2010 Jul; 18(7):426-35. PMID: 20595135.
      Citations:    
    55. Butler C, Butler WM, Rizvi AA. Sustained remission with the kinase inhibitor sorafenib in stage IV metastatic adrenocortical carcinoma. Endocr Pract. 2010 May-Jun; 16(3):441-5. PMID: 20061282.
      Citations:    
    56. Rizvi AA. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am J Med Sci. 2009 Oct; 338(4):310-8. PMID: 19726972.
      Citations:    
    57. Rizzo M, Rizvi AA, Spinas GA, Rini GB, Berneis K. Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors. Expert Opin Investig Drugs. 2009 Oct; 18(10):1495-503. PMID: 19758106.
      Citations:    
    58. Rizvi AA, McLaughlin N. Impact of comprehensive diabetes specialty care in the management of older adults with stage 3 or 4 nephropathy. South Med J. 2009 Sep; 102(9):985. PMID: 19668037.
      Citations:    
    59. Rizzo M, Rizvi AA, Rini GB, Berneis K. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetol. 2009 Mar; 46(1):1-11. PMID: 18925358.
      Citations:    
    60. Narasimhan K, Rizvi AA. Vitamin D levels in patients seen in the diabetes unit of an academic medical center. South Med J. 2008 Oct; 101(10):1069. PMID: 18791513.
      Citations:    
    61. Davis RM, Hitch AD, Nichols M, Rizvi A, Salaam M, Mayer-Davis EJ. A collaborative approach to the recruitment and retention of minority patients with diabetes in rural community health centers. Contemp Clin Trials. 2009 Jan; 30(1):63-70. PMID: 18824135.
      Citations:    
    62. Rizvi AA. 46, XX man with SRY gene translocation: cytogenetic characteristics, clinical features and management. Am J Med Sci. 2008 Apr; 335(4):307-9. PMID: 18414071.
      Citations:    
    63. Rizvi AA. Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome. Chin Med J (Engl). 2007 Nov 05; 120(21):1918-24. PMID: 18067768.
      Citations:    
    64. Rizvi AA. "Thyrotoxic psychosis" associated with subacute thyroiditis. South Med J. 2007 Aug; 100(8):837-40. PMID: 17713314.
      Citations:    
    65. Rizvi AA. Care of patients with diabetes who are undergoing surgery. JAAPA. 2007 Apr; 20(4):36, 38, 41-2 passim. PMID: 17484330.
      Citations:    
    66. Rizvi AA. Management of diabetes in older adults. Am J Med Sci. 2007 Jan; 333(1):35-47. PMID: 17220692.
      Citations:    
    67. Sonnier CS, Rizvi AA. Parasellar meningioma resembling a pituitary tumor. Endocr Pract. 2007 Jan-Feb; 13(1):86-8. PMID: 17360308.
      Citations:    
    68. Wang S, Rizvi AA. Levofloxacin-induced hypoglycemia in a nondiabetic patient. Am J Med Sci. 2006 Jun; 331(6):334-5. PMID: 16775443.
      Citations:    
    69. Schenck JB, Rizvi AA, Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am J Med Sci. 2006 Mar; 331(3):154-6. PMID: 16538077.
      Citations:    
    70. Rizvi AA, Sanders MB. Assessment and monitoring of glycemic control in primary diabetes care: monitoring techniques, record keeping, meter downloads, tests of average glycemia, and point-of-care evaluation. J Am Acad Nurse Pract. 2006 Jan; 18(1):11-21. PMID: 16403208.
      Citations:    
    71. Rizvi AA. The role of inflammation in diabetes and its complications. South Med J. 2006 Jan; 99(1):8-9. PMID: 16466109.
      Citations:    
    72. Rizvi AA. Current trends in diabetes management. JAAPA. 2005 Aug; 18(8):23-9. PMID: 16119012.
      Citations:    
    73. Tandon PK, Rizvi AA. Hypocalcemia and parathyroid function in metastatic prostate cancer. Endocr Pract. 2005 Jul-Aug; 11(4):254-8. PMID: 16006299.
      Citations:    
    74. Rizvi AA. Type 2 diabetes: epidemiologic trends, evolving pathogenetic [corrected] concepts, and recent changes in therapeutic approach. South Med J. 2004 Nov; 97(11):1079-87. PMID: 15586598.
      Citations:    
    75. Rizvi AA. Some clues and pitfalls in the diagnosis of acromegaly. Endocr Pract. 2004 Jul-Aug; 10(4):348-52. PMID: 15760780.
      Citations:    
    76. Rizvi AA. Recognition and implications of the metabolic syndrome. J S C Med Assoc. 2004 Apr; 100(4):107-12. PMID: 15162668.
      Citations:    
    77. Rizvi AA, Bowman MA, Vaughters RB, Isales C, Mulloy AL. Primary ovarian lymphoma manifesting with severe hypercalcemia. Endocr Pract. 2003 Sep-Oct; 9(5):389-93. PMID: 14583422.
      Citations:    
    78. Rizvi AA, Bowman MA. Thiazolidinedione therapy in a patient with diabetes after cardiac transplantation. Endocr Pract. 2002 Jul-Aug; 8(4):287-91. PMID: 12173915.
      Citations:    
    Rizvi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (289)
    Explore
    _
    Co-Authors (18)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _